Literature DB >> 8095818

Glutamate antagonists in the reticular formation reduce the acoustic startle response.

W Krase1, M Koch, H U Schnitzler.   

Abstract

A previous study has shown that the acoustic responsiveness of reticulospinal neurones in the caudal pontine reticular nucleus (PnC) is reduced by glutamate antagonists. It was postulated that the acoustic startle response is mediated by glutamate receptors on PnC-neurones. In the present study, we tested this hypothesis by local microinjections of different glutamate antagonists into the PnC of unrestrained awake rats. In order to differentiate the drug effects on the head and body startle responses, we measured the head startle response electromyographically, and the body startle response in a ballistic chamber. Both the AMPA/kainate and the NMDA receptor antagonists reduced both components of the startle response dose-dependently. We conclude that both subtypes of ionotropic glutamate receptors in the PnC are relevant for the acoustic startle response in rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095818     DOI: 10.1097/00001756-199301000-00003

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Cerebellar and extracerebellar involvement in mouse eyeblink conditioning: the ACDC model.

Authors:  Henk-Jan Boele; Sebastiaan K E Koekkoek; Chris I De Zeeuw
Journal:  Front Cell Neurosci       Date:  2010-01-04       Impact factor: 5.505

2.  Sleep duration varies as a function of glutamate and GABA in rat pontine reticular formation.

Authors:  Christopher J Watson; Ralph Lydic; Helen A Baghdoyan
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

3.  Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle response in the rat.

Authors:  M Koch; M Kungel; H Herbert
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 4.  Acoustic startle modification as a tool for evaluating auditory function of the mouse: Progress, pitfalls, and potential.

Authors:  Amanda M Lauer; Derik Behrens; Georg Klump
Journal:  Neurosci Biobehav Rev       Date:  2017-03-19       Impact factor: 8.989

5.  Traumatic brain injury impairs sensorimotor function in mice.

Authors:  Adrian M Sackheim; David Stockwell; Nuria Villalba; Laurel Haines; Chary L Scott; Sheila Russell; Sayamwong E Hammack; Kalev Freeman
Journal:  J Surg Res       Date:  2017-02-23       Impact factor: 2.192

6.  Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats.

Authors:  K Wedzony; K Gołembiowska; M Zazula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

7.  A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis.

Authors:  Y Lee; D E López; E G Meloni; M Davis
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

8.  Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms.

Authors:  Daniel Klamer; Erik Pålsson; Aron Revesz; Jörgen A Engel; Lennart Svensson
Journal:  Psychopharmacology (Berl)       Date:  2004-06-02       Impact factor: 4.530

9.  Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats.

Authors:  Takashi Uehara; Tomiki Sumiyoshi; Tomonori Seo; Hiroko Itoh; Tadasu Matsuoka; Michio Suzuki; Masayoshi Kurachi
Journal:  Psychopharmacology (Berl)       Date:  2009-04-16       Impact factor: 4.530

10.  The amygdala modulates prepulse inhibition of the auditory startle reflex through excitatory inputs to the caudal pontine reticular nucleus.

Authors:  Jose Carlos Cano; Wanyun Huang; Karine Fénelon
Journal:  BMC Biol       Date:  2021-06-03       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.